Who We are
The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.
News and Events
Boston Children’s Technology Development Fund launches 2017 funding cycle
Letters of Intent (LOI) are due on Feb. 8, 2017. To learn more about TDF, please join us for an informational lunch seminar on Wednesday, January 18, 2017, 12 - 1 pm in the Karp 7 Conference room. Pizza will be provided, so please RSVP to email@example.com.
FY 2015 TIDO Annual Report Released
Fiscal Year 2015 was a year of growth at TIDO. Boston Children’s executed 48 licenses, a 42 percent increase over the prior year, while the total number of executed industry research and license agreements reached 91, an increase of 17 percent over the prior year. The report highlights selected agreements, Technology Development Fund award winners, and some of our technologies available for licensing.
Updated Material Transfer Agreement (MTA) Procedures (Click here)
The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.